Case Report
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Jan 15, 2024; 16(1): 234-243
Published online Jan 15, 2024. doi: 10.4251/wjgo.v16.i1.234
Table 3 Rat sarcoma virus mutation status and survival outcomes after second line and third line treatment
PFS 2L (mo)
OS since 2L (mo)
PFS 3L (mo)
OS since 3L (mo)
Case 1Wild-type35.8646.61Wild-type6.219.96
Case 2Mutated3.5433.57Neo-RAS3.8629.50
Case 3Mutated24.3944.82Mutated8.9612.50
Case 4Mutated11.2528.64Mutated3.7916.39
Case 5Mutated9.2934.61Mutated5.1823.57
Case 6Mutated11.2514.71Mutated2.292.29
Case 7Wild-type14.5427.64Wild-type5.1411.71
Case 8Mutated3.794.43NANANA
Case 9Mutated18.9632.39Mutated3.0712.43
Case 10Mutated4.7920.93Mutated12.9312.93
Case 11Wild-type8.398.39NANANA